Compositions and methods of use of Atype procyanidins

Details for Australian Patent Application No. 2005209317 (hide)

Owner Mars, Incorporated

Inventors Kelm, Mark A.; Schmitz, Harold H.; Kwik-Uribe, Catherine L.; Hammerstone, John F. Jr.

Agent Watermark

Pub. Number AU-B-2005209317

PCT Pub. Number WO2005/072726

Priority 60/539,689 28.01.04 US

Filing date 28 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 7 July 2011

International Classifications

A61K 31/353 (2006.01)

A61K 31/7048 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072726 Priority application(s): WO2005/072726

7 July 2011 Application Accepted

  Published as AU-B-2005209317

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209318-Functionalized colloidal metal compositions and methods

2005209310-Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPH-inhibitor for the treatment of central nervous system-related conditions